Active, not recruitingPhase 3NCT04024163
Prospective Study of Benznidazole for Chagas' Disease Children With Chronic Indeterminate Chagas Disease
Studying American trypanosomiasis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Insud Pharma
- Intervention
- Benznidazole(drug)
- Enrollment
- 178 enrolled
- Eligibility
- 2-18 years · All sexes
- Timeline
- 2019 – 2028
Study locations (9)
- Hospital de Ninos "Dr. Ricardo Gutierrez", Buenos Aires, Argentina
- Hospital "Luis Carlos Lagomaggiore", Mendoza, Argentina
- Hospital Pediatrico "Dr. Humberto Notti", Mendoza, Argentina
- Hospital Público Descentralizado Dr. Guillermo Rawson, San Juan, Argentina
- Centro de Enfermedad de Chagas y Patologías Regionales, Santiago del Estero, Argentina
- Antigua Hospital Viedma, Cochabamba, Bolivia
- CEADES - Plataforma de Chagas Sucre, Sucre, Bolivia
- Fundación Salud para el Trópico, Santa Marta, Colombia
- Centro de Atención e Investigación Médica (CAIMED), Yopal, Colombia
Collaborators
Chemo Research
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04024163 on ClinicalTrials.govOther trials for American trypanosomiasis
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT06632600A Study of Efficacy, Safety, Tolerability of LXE408 in Participants With Chronic Chagas Disease.Novartis Pharmaceuticals
- ENROLLING BY INVITATIONNCT07033325University-Based Chagas Testing in Salta Province, ArgentinaMundo Sano Foundation
- RECRUITINGPHASE3NCT04897516Shorter Benznidazole Regimens Compared to the Standard Regimen for Chagas DiseaseLaboratorio Elea Phoenix S.A.
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT04984265SBRT in Chagas Disease Ventricular TachycardiaUniversity of Sao Paulo General Hospital